Pages that link to "Q42451954"
Jump to navigation
Jump to search
The following pages link to Antiproliferative effect in human prostatic smooth muscle cells by nitric oxide donor (Q42451954):
Displaying 26 items.
- Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression (Q22254649) (← links)
- iNOS enhances rat intestinal apoptosis after ischemia-reperfusion (Q28566908) (← links)
- 2-Phenyl-5-(pyrrolidin-1-yl)-1-(3,4,5-trimethoxybenzyl)-1H-benzimidazole, a benzimidazole derivative, inhibits growth of human prostate cancer cells by affecting tubulin and c-Jun N-terminal kinase (Q34116798) (← links)
- KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora A activity. (Q35005238) (← links)
- Elevation of soluble guanylate cyclase suppresses proliferation and survival of human breast cancer cells (Q35558572) (← links)
- The relationship between erectile dysfunction and lower urinary tract symptoms: epidemiological, clinical, and basic science evidence (Q35839581) (← links)
- The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms (Q37209592) (← links)
- PDE5 inhibitors for LUTS. (Q37581408) (← links)
- Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways (Q37718328) (← links)
- Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction (Q37719924) (← links)
- Association of lower urinary tract symptoms and erectile dysfunction: pathophysiological aspects and implications for clinical management (Q37877132) (← links)
- The use of PDE-5 inhibitors in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (Q38153654) (← links)
- A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway (Q38977013) (← links)
- Denbinobin induces apoptosis by apoptosis-inducing factor releasing and DNA damage in human colorectal cancer HCT-116 cells. (Q39964024) (← links)
- Investigation of anti-tumor mechanisms of K2154: characterization of tubulin isotypes, mitotic arrest and apoptotic machinery (Q40208807) (← links)
- Melatonin decreases cell proliferation and transformation in a melatonin receptor-dependent manner (Q42803894) (← links)
- Testosterone- and phorbol ester-stimulated proliferation in human cultured prostatic stromal cells (Q43767566) (← links)
- The bradykinin/soluble guanylate cyclase signaling pathway is impaired in androgen-independent prostate cancer cells. (Q43875279) (← links)
- Characterization of some novel alpha 1-adrenoceptor antagonists in human hyperplastic prostate (Q44028373) (← links)
- Vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia (Q44286258) (← links)
- Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells (Q44668320) (← links)
- Terfenadine induces anti-proliferative and apoptotic activities in human hormone-refractory prostate cancer through histamine receptor-independent Mcl-1 cleavage and Bak up-regulation. (Q53089642) (← links)
- Drug Concentration in Rat Plasma, Bladder, and Prostate After Mirodenafil Administration in a Chronic Pelvic Ischemia Model. (Q53163119) (← links)
- Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide. (Q55338911) (← links)
- Cell proliferation in human prostatic smooth muscle cells involves the modulation of protein kinase C isozymes (Q77614356) (← links)
- Sexual Function and alpha-Blockers (Q80297412) (← links)